Exclusive licensing Hairpin Technologies serves as the exclusive licensing agent for the ShRNA tech from Cold Spring Harbor Laboratory, presenting a clear sales angle to potential licensees and manufacturers seeking authorized access and distribution rights.

Small team leverage With a lean team and a focus on out-licensing, there is an opportunity to position partner-driven growth, leveraging channel partners and distributors to accelerate market reach for shRNA tools without substantial internal headcount.

Patent shield A robust portfolio of U.S. and international patents around shRNA can be highlighted to potential licensees as a defensible moat, reducing competitive risk and enabling premium licensing terms.

Targeted outreach Current activity in marketing and corporate outreach suggests a ripe window for strategic outreach to biotech manufacturers, contract research organizations, and academic supply vendors looking to expand shRNA offerings.

Low-revenue opportunity Revenue under $1M indicates growth potential through expanded licensing deals, co-development arrangements, and reseller partnerships with larger biopharma and CRO networks seeking to add shRNA capabilities.